Novartis CEO Vas Narasimhan on Drug Development & AI's Role in Disease Treatment
CEO & Founder Conversations
•
30m
The pharmaceutical industry is experiencing extraordinary innovation, fueled by breakthroughs in science, technology, and data analytics. Novartis (NYSE: NVS) stands as a driving force in this wave of transformation. From gene and cell therapies to targeted cancer treatments and immunology, Novartis consistently delivers solutions for some of the most complex health problems. CEO Vas Narasimhan goes Inside the ICE House to discuss the significant success achieved and how the company, under his leadership, sharpened its focus on innovative medicines to combat some of the world's most pressing medical challenges.
Up Next in CEO & Founder Conversations
-
IPC CEO Kurt Adams on Innovation, Acq...
In September 2024, ICE and IPC Systems partnered to launch ICE Voice, a powerful new tool that leverages IPC's existing capabilities. ICE Voice facilitates seamless, persistent connections within ICE Chat's extensive network of over 120,000 users. IPC Systems CEO Kurt Adams joins ICE's Chris Edmo...
-
Snowflake CEO Sridhar Ramaswamy on Tr...
AI's rapid evolution is transforming the business landscape, driving efficiency, automating processes, and uncovering new opportunities. Under the leadership of CEO Sridhar Ramaswamy, Snowflake (NYSE: SNOW) has emerged as a pioneer in harnessing AI to revolutionize how organizations utilize data ...
-
Philips CEO Roy Jakobs on AI in Healt...
The healthcare industry has seen remarkable transformation over recent decades, evolving from a reactive care model to a proactive, patient-centered approach. At the forefront of this evolution is artificial intelligence, which is revolutionizing healthcare by enhancing diagnostic accuracy, perso...
